Cicala Peter

CIK: 0002011534

Director

Primary company: Eterna Therapeutics Inc. (ERNA)

Cicala Peter is a corporate insider at Eterna Therapeutics Inc. (ERNA) filing SEC Form 4 transactions. 4 transactions. Source: SEC EDGAR.

Total Transactions

Total Buy Value

Total Sell Value

Net Activity

Last Transaction

Sep 2026

Companies

Transaction History

Filter:

Source: SEC EDGAR Form 4 insider transaction filings.

Company	Type	Shares	Price	Value	Shares After	Date	SEC
Ernexa Therapeutics Inc. ERNA	Award	5,083	$4.57	$23K	5,083	8/31/2026 Filed: 8/31/2026	Filing →
Ernexa Therapeutics Inc. ERNA	Award	5,943	$4.57	$27K	5,943	8/31/2026 Filed: 8/31/2026	Filing →
Eterna Therapeutics Inc. ERNA	Award	51,485	$0.34	$18K	51,485	2/7/2025 Filed: 2/10/2025	Filing →
Eterna Therapeutics Inc. ERNA	Award	88,946	-	-	88,946	4/26/2024 Filed: 4/29/2024	Filing →

Ernexa Therapeutics Inc.

ERNA

Type

Award

5,083

Price

$4.57

Value

$23K

Ernexa Therapeutics Inc.

ERNA

Type

Award

5,943

Price

$4.57

Value

$27K

Eterna Therapeutics Inc.

ERNA

Type

Award

51,485

Price

$0.34

Value

$18K

Eterna Therapeutics Inc.

ERNA

Type

Award

88,946

Price

Value

AI Agent

Try asking...